CARDIAC amyloidosisEARLY diagnosisCARDIAC magnetic resonance imagingThis article provides information on the diagnosis and management of cardiac amyloidosis (CA), a condition characterized by abnormal protein deposits in the heart tissue. CA can be caused by two main types of amyloidosis: light ...
Cardiac amyloidosis is a manifestation of one of several systemic diseases known as the amyloidoses.1,2 This uncommon disease is probably underdiagnosed, and even when a diagnosis of amyloidosis of the heart is made, the fact that there are several types of amyloid, each with its unique feature...
Emerging Advances in the Management of Cardiac Amyloidosis Amyloidosis is a disease in which proteins misfold, aggregate into fibrils, and deposit extracellularly disrupting organ architecture and function. There a... MN Vranian,BW Sperry,J Valent,... - 《Current Cardiology Reports》 被引量: 5发...
Introduction: Cardiac amyloidosis is a disorder caused by the accumulation of abnormal protein products, amyloid, in the myocardium which subsequently impairs normal heart function. Heart failure with preserved ejection fraction has been increasingly attributed to amyloidosis and the resultant restrictive ...
Evaluation and Management of the Cardiac Amyloidosis [Erratum to document cited in CA148:253001].Evaluation and Management of the Cardiac Amyloidosis [Erratum to document cited in CA148:253001].Selvanayagam, Joseph BHawkins, Philip NPaul, BijuMyerson...
Cardiac amyloidosis is a form of infiltrative cardiomyopathy typically presenting with progressive heart failure. The clinical presentation and morphological findings often overlap with other cardiovascular diseases, and frequently results in misdiagnosis and consequent under-reporting. Cardiovascular imaging is pl...
1,4,76,78 Position statements on the evaluation and management of patients with cardiac amyloidosis do not address women-specific experiences or treatments, likely due to a lack of available evidence.79 Specific recommendations and guidelines around heart failure specific to women in Canada are ...
Clinical and genetic profiles of patients with hereditary and wild type transthyretin amyloidosis: the transthyretin cardiac amyloidosis registry in the st... INTRODUCTION. Transthyretin amyloidosis (ATTR) is a multisystem disease caused by the deposition of fibrillar protein in organs and tissues. ATTR ...
Typical HFpEF must be distinguished from other causes of the clinical syndrome of heart failure, which are treated differently. Diagnosis is challenging and requires the demonstration of objective evidence of congestion or poor cardiac output using assessment of clinical history, physical examination, natr...
Cardiac amyloidosis (CA) is a rare but potentially life-threatening disease in which misfolded proteins accumulate in the cardiac wall tissue. Heart rhythm disorders in CA, including supraventricular arrhythmias, conduction system disturbances, or ventricular arrhythmias, play a major role in CA morbidity...